Emergent Biosolutions, Inc. (EBS) financial statements (2021 and earlier)

Company profile

Business Address 400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG, MD 20879
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments621168112178272313280
Cash and cash equivalents621168112178272313280
Restricted cash and investments0001   
Receivables23127527114614812760
Inventory, net of allowances, customer advances and progress billings307223206143747766
Inventory307223206143747766
Deferred costs  1    
Other undisclosed current assets37203017162226
Total current assets:1,196686621485510539432
Noncurrent Assets
Property, plant and equipment644542510407376332314
Intangible assets, net (including goodwill)9309801,02116975112100
Goodwill26726726049415542
Intangible assets, net (excluding goodwill)663713762120345758
Other noncurrent assets11377146278
Other undisclosed noncurrent assets 4263365491
Total noncurrent assets:1,6871,6411,609585460505513
TOTAL ASSETS:2,8832,3272,2291,0709701,044945
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26819717484768779
Accounts payable136958142354641
Accrued liabilities4740315666
Employee-related liabilities85625838353532
Taxes payable  5    
Debt 1310 20  
Deferred revenue and credits13785
Contract with customer, liability11
Other liabilities834     
Other undisclosed current liabilities34362359
Total current liabilities:38521620010010610093
Noncurrent Liabilities
Long-term debt and lease obligation84179878513248253251
Long-term debt, excluding current maturities84179878513248253251
Liabilities, other than long-term debt211134179341087
Deferred revenue and credits17876
Accounts payable and accrued liabilities  1113   
Deferred revenue56 
Contract with customer, liability8663
Deferred tax liabilities, net68    
Deferred income tax liabilities53 
Other liabilities6849385211
Business combination, contingent consideration, liability34      
Other undisclosed noncurrent liabilities 905410102341
Total noncurrent liabilities:1,0521,0231,01858268284299
Total liabilities:1,4361,2391,219158374384392
Stockholders' equity
Stockholders' equity attributable to parent1,4471,0891,011912596660553
Common stock0000000
Treasury stock, value(40)(40)(40)(39)(6)(6)(6)
Additional paid in capital785716689618352318274
Accumulated other comprehensive loss(25)(10)(6)(4)(4)(3)(3)
Retained earnings727422367337254351288
Total stockholders' equity:1,4471,0891,011912596660553
TOTAL LIABILITIES AND EQUITY:2,8832,3272,2291,0709701,044945

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1,5551,106782561489523450
Revenue, net561489523450
Cost of revenue
(Cost of Goods and Services Sold)
(524)(434)(322)(196)(131)(124)(118)
Gross profit:1,031673460365357398332
Operating expenses(1,122)(992) (241)(252)(302)(298)
Other undisclosed operating income (loss)524434(370)   24
Operating income:434114901241069658
Nonoperating expense(27)(37)(8)(6)(6)(6)(5)
Investment income, nonoperating   2110
Other nonoperating income (expense)522(1)0(0)3
Interest and debt expense(31)(38)(10)(7)(8)(7)(8)
Other undisclosed income from continuing operations before equity method investments, income taxes3138107878
Income from continuing operations before income taxes:4077782119999053
Income tax expense(102)(23)(19)(36)(37)(27)(16)
Income from continuing operations:305556383636337
Loss from discontinued operations    (11)  
Net income available to common stockholders, basic:305556383526337
Interest on convertible debt    333
Net income available to common stockholders, diluted:305556383556640

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:305556383526337
Other comprehensive loss (0)(2)    
Other undisclosed comprehensive income (loss)   1(2)00
Comprehensive income:305546183506337
Other undisclosed comprehensive loss, net of tax, attributable to parent(15)(4)     
Comprehensive income, net of tax, attributable to parent:290506183506337

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: